Posts Tagged: "PatentSight"

IPW Webinar – Chasing Technology Unicorns – How To Spot Acquisition Targets Early On

The decision to “make” or “buy” is one of, if not, the most important decisions that corporate decision makers have to make when it comes to developing ground-breaking technology. This is the decision that can set the tone of success or loss of a company in a technology race that could define the next decades of an industry. In this…

IPW Webinar – Where do we stand in fighting pandemics caused by bacteria? – Sponsored By PatentSight

  Looking at the patent landscape of antibiotics to identify global leaders As the global research community is scrambling to develop solutions and help the world recover from the impact of Covid-19, we should not stay blind to other medical risks on the horizon which should be addressed. Chief among these is drug resistant bacteria, a risk which could potentially…

IPW Webinar – How Classification Works at the USPTO and the Implications for Software Patents and Computer Related Innovations

  What is the difference between class 705 and class 706? There is much more than a single number, and in some instances whether your patent application is primarily lodged in class 705 instead of 706 that could likely mean you will be routed to an Art Unit with a very low, perhaps extremely low, allowance rate. In a nutshell,…

IPW Webinar – Using patent analytics to maintain a world class portfolio

In this webinar, a panel consisting of leaders in academic innovation research and industrial innovation experts, define a world-class patent portfolio from their perspectives. They will also discuss how to implement processes in organisations to develop and maintain such a patent portfolio. By combining these perspectives, the discussion will arrive at the requirements for software applications that are capable to…

IPW Webinar – The Antiviral Patent Landscape

  With the novel coronavirus spreading both fear and illness across the world, it is a worthwhile exercise to look at the patent landscape of antiviral vaccines. By analyzing  both the quality and quantity of the patent portfolios of the world’s leading manufacturers and researchers, it is possible to evaluate the companies and research institutes  that are at the forefront…

‘Not Just Another G’: Apple’s Intel Purchase Underscores the Sprint to 5G

Earlier this summer, Intel announced that some 8,500 patent assets (i.e., issued patents and pending patent applications) would be auctioned. Approximately 6,000 assets related to 3G, 4G, and 5G cellular standards, while 1,700 assets relate to wireless implementation of cellular standards. According to initial reports from IAM, Intel was hoping to sell these patents separately from the smartphone modem business, although they were open to the possibility that a prospective buyer might seek to acquire both the patent assets and Intel’s smartphone modem business. Shortly after the Intel patent assets were announced as available for sale, Intel abruptly took the assets off the market in favor of negotiating with a single interested suitor. Very quickly, news broke that the negotiations with that unidentified suitor were quite advanced, suggesting that the Intel auction announcement was nothing more than a negotiating ploy to get the unidentified suitor back to the table and for the suitor to realize that they could lose the patent assets if they did not play their hand correctly and misidentified the leverage involved in the negotiation. It has recently come to light that the unidentified suitor for the Intel patent assets was none other than Apple, just as IAM has predicted in its initial reporting. So, now we know that Apple will buy the majority of Intel’s modem business, including the patent assets, for $1 billion.